Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Placebo Controlled Trial to Determine the Efficacy and Mode of Action of Ondansetron in the Treatment of Irritable Bowel Syndrome With Diarrhoea

NCT03555188 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT03555188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03555188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Placebo Controlled Trial to Determine the Efficacy and Mode of Action of Ondansetron in the Treatment of Irritable Bowel Syndrome With Diarrhoea
Lead sponsor
University of Leeds
Phase
Phase 3
Overall status
Completed
Start date
March 29, 2018
Completion date
September 10, 2020
Enrollment
80 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome